Cargando…
Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity
Liver cancer is the leading cause of cancer-related mortality worldwide and its incidence is increasing. Considerable effort has been made in recent decades to improve the diagnosis and treatment of liver cancer. Advanced liver cancer often exhibits a poor response to chemotherapy and poor prognosis...
Autores principales: | Hu, Jia-Qing, Deng, Fang, Hu, Xiao-Ping, Zhang, Wei, Zeng, Xiao-Chen, Tian, Xue-Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196608/ https://www.ncbi.nlm.nih.gov/pubmed/30542728 http://dx.doi.org/10.3892/or.2018.6770 |
Ejemplares similares
-
The histone deacetylase SIRT6, a critical modulator of metabolism and tumorigenesis
por: Sebastian, Carlos, et al.
Publicado: (2012) -
An inactivating mutation in the histone deacetylase SIRT6 causes human perinatal lethality
por: Ferrer, Christina M., et al.
Publicado: (2018) -
SIRT6 histone deacetylase functions as a potential oncogene in human melanoma
por: Garcia-Peterson, Liz Mariely, et al.
Publicado: (2017) -
The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
por: Samant, Sadhana A., et al.
Publicado: (2017) -
Contributions of a Histone Deacetylase (SirT2/Hst2) to Beauveria bassiana Growth, Development, and Virulence
por: Cai, Qing, et al.
Publicado: (2022)